TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
66.87
66.87
Range Annuel
23.30
69.20
Changement quotidien
-3.13%
Changement Mensuel
+16.30%
Evolution sur 6 mois
+114.05%
Changement Annuel
+133.73%
Clôture Précédente
69.0 3
Open
66.8 7
Low
66.8 7
High
66.8 7
Volume
165
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Nouvelles